Analysed Cognition Therapeutics Inc (CGTX:NASDAQ) News Sources
Cognition Therapeutics Advancing Zervimesine (CT1812) for Dementia with Lewy Bodies (DLB) Psychosis
Yahoo Finance
The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
Yahoo Finance
Cognito Therapeutics raises $105M for Alzheimer’s therapeutic advancement
Medical Device Network on MSN
Pharma Funding Roundup: Cognito Therapeutics Closes Oversubscribed $105 Million Series C Financing, Nexcure Launches $19 Million Series A Financing
PharmExec
Voyager Therapeutics, Inc. (VYGR) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript
Seeking Alpha
US FDA lifts clinical hold of Intellia Therapeutics’ MAGNITUDE phase 3 trial of nex-z for patients with transthyretin amyloidosis with cardiomyopathy
Pharmabiz
How Investors May Respond To Stoke Therapeutics (STOK) NEJM Data And 2027 FDA Filing Timeline
Yahoo Finance UK
Cognito Therapeutics Announces Oversubscribed $105 Million Series C Financing to Advance Spectristm in Alzheimer's Disease
Le Lézard
Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms
Yahoo Finance UK
What is the current price of Cognition Therapeutics Inc (CGTX:NASDAQ)?
The current price of Cognition Therapeutics Inc (CGTX:NASDAQ) is $1.03.
Cognition Therapeutics Inc (CGTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of Cognition Therapeutics Inc (CGTX:NASDAQ) since the previous trading day is $-0.01.
Cognition Therapeutics Inc (CGTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of Cognition Therapeutics Inc (CGTX:NASDAQ) since the previous trading day is -0.96%.
What is This Week's average sentiment score for Cognition Therapeutics Inc (CGTX:NASDAQ)?
This Week's average sentiment score for Cognition Therapeutics Inc (CGTX:NASDAQ) is 82 out of 100.
What is This Week's average sentiment for Cognition Therapeutics Inc (CGTX:NASDAQ)?
This Week's sentiment for Cognition Therapeutics Inc (CGTX:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.